CEO/Chair, Council of Experts Topics The Basics Management The FutureScience The FuturePutting It Together Topics The Basics Management The FutureScience The FuturePutting It Together Key Elements of Science & Standards Division: Organization Flow Drivers for Change Increase/improve interface between different parts of USP Increase efficiency on work flow within SSD External to USP Internal within USP Expert Committees were recently restructured to manage monographs and reference standards To make project ownership for each product clear (single point of accountability in the context of the team) Maximize capacity of our work load (identify constraints and provide solutions) Drivers For Change: Outcomes Products (monographs, reference materials) to our customers are synchronized and reference standards are available as early as possible There is a portfolio owner for each segment of the portfolio for Small Molecules, Biologics, Excipients, Dietary Supplements, Food Ingredients, General Chapters/Pharmacists Pharmacopeia, Healthcare Quality Standards A uniform criteria for priority setting
Growth hormone peptides like sermorelin cost $200-$400 monthly, significantly less than GLP-1 agonists, because the market is smaller and manufacturing is simpler
Be wary of clinics promising unrealistic outcomes with no mentioned downsides
Inhalation therapy is another promising approach, delivering glutathione directly to the lungs and bloodstream
local inflammations and allergic reactions
The hospital pharmacies segment held a 28% share of the market in 2025 and is expected to grow at a CAGR of 8.5% during the projection period
